Linzagolix0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Linzagolix — research data
Regulatory statusEMA-approved (Yselty)
NCAA D1Banned
Overview
About Linzagolix
Mechanism of action
Oral GnRH receptor antagonist; partial or complete estrogen suppression
Safety profile
Hot flashes, headache, bone density changes · Approved in EU for uterine fibroids; bone density monitoring; newer but well-studied
Related pages